8-K: Patterson Companies Completes Acquisition by Patient Square Capital for $2.8 Billion, Delists from NASDAQ

Sentiment:

Merger Announcement


Patterson Companies, Inc. has completed its acquisition by Patient Square Capital, resulting in the company becoming a private entity and delisting from the NASDAQ.

Summary

  • Patterson Companies, Inc. has finalized its merger agreement with Paradigm Parent, LLC, an indirect subsidiary of Patient Square Capital, on April 17, 2025.
  • The merger resulted in Patterson Companies becoming a wholly-owned subsidiary of Paradigm Parent, LLC.
  • Each share of Patterson Companies' common stock was converted into the right to receive $31.35 in cash.
  • Outstanding stock options and restricted stock units were cashed out, with performance-based restricted stock units vesting based on target level achievement.
  • The company's existing indebtedness under the Credit Agreement and Note Purchase Agreement was discharged and the agreements terminated.
  • Patterson Companies' common stock has been delisted from the NASDAQ, and the company intends to terminate its registration with the SEC.
  • The aggregate consideration paid to Patterson Companies shareholders was approximately $2.8 billion, funded through equity and debt financing.
  • Following the merger, the board of directors, excluding Donald J. Zurbay, resigned, and Kevin M. Barry was appointed as a director.
  • The company's Restated Articles of Incorporation and Amended and Restated Bylaws were amended and restated.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition provides shareholders with immediate cash value, and the company gains new ownership. However, the delisting may be viewed negatively by some investors.

Positives

  • Shareholders received a cash payment of $31.35 per share.
  • The company's debt obligations have been cleared.
  • The transaction provides Patterson Companies with new ownership and strategic direction under Patient Square Capital.

Negatives

  • Patterson Companies is no longer a publicly traded company, limiting investment opportunities for public investors.
  • The delisting from NASDAQ means the stock is no longer traded on a major exchange.

Risks

  • As a private company, Patterson Companies will have less transparency and public reporting requirements.
  • The success of the acquisition depends on the strategic decisions and management of Patient Square Capital.

Future Outlook

The company will operate as a wholly-owned subsidiary of Paradigm Parent, LLC, an affiliate of Patient Square Capital. The future direction and strategy will be determined by the new ownership.

Industry Context

The acquisition reflects the ongoing trend of private equity firms investing in healthcare-related companies. This move could allow Patterson Companies to focus on long-term growth strategies without the pressures of quarterly earnings reports.

Comparison to Industry Standards

  • Similar acquisitions in the healthcare distribution industry have seen private equity firms focusing on operational efficiencies and strategic expansion.
  • Comparable companies that have undergone similar transactions include [hypothetical company A] and [hypothetical company B], which experienced [hypothetical result A] and [hypothetical result B] respectively after being acquired.
  • The $2.8 billion valuation is within the typical range for acquisitions of companies with Patterson Companies' revenue and market position.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorJohn D. BuckApril 17, 2025Resignation in connection with the Merger
DirectorMeenu AgarwalApril 17, 2025Resignation in connection with the Merger
DirectorAlex N. BlancoApril 17, 2025Resignation in connection with the Merger
DirectorJody H. FeragenApril 17, 2025Resignation in connection with the Merger
DirectorRobert C. FrenzelApril 17, 2025Resignation in connection with the Merger
DirectorPhilip G.J. McKoyApril 17, 2025Resignation in connection with the Merger
DirectorNeil A. SchrimsherApril 17, 2025Resignation in connection with the Merger
DirectorPamela J. TomczikApril 17, 2025Resignation in connection with the Merger
DirectorKevin M. BarryApril 17, 2025Appointment as Director

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
AmendmentThe Companys Restated Articles of Incorporation were amended and restated in their entirety.April 17, 2025The Amended and Restated Articles of Incorporation reflect the new ownership structure and governance of the company as a private entity.
AmendmentThe Companys Amended and Restated Bylaws were amended and restated in their entirety.April 17, 2025The Second Amended and Restated Bylaws outline the operational and governance procedures for the company under its new ownership.

Stakeholder Impact

  • Shareholders received cash consideration for their shares.
  • Employees will continue their roles, as the officers of the company remained the same immediately following the Effective Time.
  • The company's customers and suppliers may experience changes based on the strategic direction set by the new ownership.

Next Steps

  • Patterson Companies will operate as a private entity under the ownership of Paradigm Parent, LLC.
  • The company intends to file a certification and notice of termination of registration on Form 15 with the SEC.
  • The new board of directors of the ultimate parent company will consist of Justin Sabet-Peyman, Trit Garg, M.D., Jonny Dorf, Brian A. McCarthy and Donald J. Zurbay.

Key Dates

DateDescription
October 28, 2022Date of the Third Amended and Restated Credit Agreement.
March 29, 2018Date of the Note Purchase Agreement.
December 10, 2024Date of the Agreement and Plan of Merger.
December 11, 2024Patterson Companies filed a Current Report on Form 8-K with the SEC regarding the Merger Agreement.
April 17, 2025Closing Date of the Merger.

Keywords

acquisition, merger, Patient Square Capital, Patterson Companies, delisting, NASDAQ, private equity, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.